Literature DB >> 7964675

Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test.

P Lysaker1, M Bell.   

Abstract

Research has suggested that poor insight in patients with schizophrenia is associated with poorer treatment compliance and outcome. Little is known about the etiology of poor insight. Poor insight has been attributed to a willful preference for illness, a psychological defense, and cognitive impairments. To test the hypothesis that poor insight is related to enduring cognitive deficits, the performance of 29 patients with schizophrenia and impaired insight and 63 patients with schizophrenia and unimpaired insight was compared on repeated administrations of the Wisconsin Card Sorting Test. Results indicate that subjects with impaired insight demonstrate consistently poorer performance over a period of 1 year than subjects with unimpaired insight. When the effects of IQ were partialled out, subjects with impaired insight made significantly more perseverative errors and achieved fewer categories correct, a pattern of performance deficits identified with neuropsychological dysfunction in schizophrenia. These results support the hypothesis that cognitive impairment may underlie poor insight in schizophrenia.

Entities:  

Mesh:

Year:  1994        PMID: 7964675     DOI: 10.1097/00005053-199411000-00010

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  15 in total

Review 1.  Insight in schizophrenia: a review.

Authors:  Marjorie Baier
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

Review 2.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

3.  Life and treatment goals of individuals hospitalized for first-episode nonaffective psychosis.

Authors:  Claire E Ramsay; Beth Broussard; Sandra M Goulding; Sarah Cristofaro; Dustin Hall; Nadine J Kaslow; Eóin Killackey; David Penn; Michael T Compton
Journal:  Psychiatry Res       Date:  2011-06-25       Impact factor: 3.222

4.  Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: the West London first episode study.

Authors:  Stanley H Mutsatsa; Eileen M Joyce; Sam B Hutton; Thomas R E Barnes
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08-04       Impact factor: 5.270

5.  Domains of awareness in schizophrenia.

Authors:  J Gilleen; K Greenwood; A S David
Journal:  Schizophr Bull       Date:  2010-09-17       Impact factor: 9.306

Review 6.  Disorders of awareness in neuropsychiatric syndromes: an update.

Authors:  Laura A Flashman
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

7.  Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?

Authors:  Joanne P Webster; Maya Kaushik; Greg C Bristow; Glenn A McConkey
Journal:  J Exp Biol       Date:  2013-01-01       Impact factor: 3.312

8.  Lack of relationship between psychological denial and unawareness of illness in schizophrenia-spectrum disorders.

Authors:  Carrie L Kruck; Laura A Flashman; Robert M Roth; Nancy S Koven; Thomas W McAllister; Andrew J Saykin
Journal:  Psychiatry Res       Date:  2009-07-17       Impact factor: 3.222

9.  Insight, cognitive dysfunction and symptomatology in schizophrenia.

Authors:  Luciana C Monteiro; Vanessa A Silva; Mario R Louzã
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

10.  Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XR.

Authors:  Philip D Harvey; Cynthia O Siu; Antony D Loebel
Journal:  Innov Clin Neurosci       Date:  2017-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.